Abuse Potential with Oral Route of Administration of a Hydrocodone Extended-Release Tablet Formulated with Abuse-Deterrence Technology in Nondependent, Recreational Opioid Users

por Darwish, Mona, Bond, Mary, Ma, Yuju, Tracewell, William, Robertson, Philmore, Webster, Lynn R.
Publicado 2017

Fremanezumab for preventive treatment of migraine: Functional status on headache-free days

por VanderPluym, Juliana, Dodick, David W., Lipton, Richard B., Ma, Yuju, Loupe, Pippa S., Bigal, Marcelo E.
Publicado 2018

Evaluation of the Relative Intranasal Abuse Potential of a Hydrocodone Extended-Release Tablet Formulated with Abuse-Deterrence Technology in Nondependent, Recreational Opioid User...

por Bond, Mary, Schoedel, Kerri A, Rabinovich-Guilatt, Laura, Gasior, Maciej, Tracewell, William, Malamut, Richard, Ma, Yuju, Webster, Lynn R
Publicado 2018

TEV-48125 for the preventive treatment of chronic migraine: Efficacy at early time points

por Bigal, Marcelo E., Dodick, David W., Krymchantowski, Abouch V., VanderPluym, Juliana H., Tepper, Stewart J., Aycardi, Ernesto, Loupe, Pippa S., Ma, Yuju, Goadsby, Peter J.
Publicado 2016